Search - tctmd.com

Displaying 321 - 340 of 808

Sort: Relevancy | Date

Presentation TCT 2013

LEVANT 2

Presenter: D. Christopher Metzger

October 31, 2013

Presentation TCT 2013

ISAR DESIRE III Trial Update

Presenter: Robert Byrne

October 31, 2013

Presentation TCT 2013

Indigenous Stents: New Technologies and Clinical Data

Presenter: Sreenivas Kumar

October 31, 2013

Presentation TCT 2013

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Presenter: Gunnar Tepe

October 31, 2013

Presentation TCT 2013

Future Directions, Clinical Applications and Local Drug Delivery Technologies

Presenter: Juan Granada

October 31, 2013

Presentation TCT 2013

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Presenter: Clemens von Birgelen

October 31, 2013

Presentation TCT 2013

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Presenter: J?rg Schr?der

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Presenter: Ron Waksman

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Presenter: Christoph Naber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data(2)

Presenter: Franz Kleber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data

Presenter: Franz Kleber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloon Mechanisms of Action: Insights From Angiography, FFR and OCT

Presenter: Pierfrancesco Agostoni

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloon Mechanisms of Action: A Transparent Review of What We Don't Know

Presenter: Robert Schwartz

October 31, 2013

Presentation TCT 2013

CVI (Covidien)

Presenter: Prakash Krishnan

October 31, 2013

Presentation TCT 2013

Current Landscape, Opportunities and Challenges for Drug-Coated Balloon Technologies

Presenter: Juan Granada

October 31, 2013

Presentation TCT 2013

Critical Review of Drug-Coated Balloon Data for the Coronary ISR Application

Presenter: Bruno Scheller

October 31, 2013

Presentation TCT 2013

Coronary Drug-Coated Balloons in De Novo Lesions: What are the Technical and Safety Considerations That Haven't Been Addressed?

Presenter: Bernardo Cortese

October 31, 2013

Presentation TCT 2013

Bit Player! DCB Will Become Dominant Therapy, With DES Reserved for Bail-Out!

Presenter: William Gray

October 31, 2013

Presentation TCT 2013

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

Presenter: Patrick Serruys

October 31, 2013

Presentation TCT 2013

Biolux (Biotronik)

Presenter: Dierk Scheinert

October 31, 2013

Advertisement

LEVANT 2

ISAR DESIRE III Trial Update

Indigenous Stents: New Technologies and Clinical Data

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Future Directions, Clinical Applications and Local Drug Delivery Technologies

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data(2)

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data

Drug-Coated Balloon Mechanisms of Action: Insights From Angiography, FFR and OCT

Drug-Coated Balloon Mechanisms of Action: A Transparent Review of What We Don't Know

CVI (Covidien)

Current Landscape, Opportunities and Challenges for Drug-Coated Balloon Technologies

Critical Review of Drug-Coated Balloon Data for the Coronary ISR Application

Coronary Drug-Coated Balloons in De Novo Lesions: What are the Technical and Safety Considerations That Haven't Been Addressed?

Bit Player! DCB Will Become Dominant Therapy, With DES Reserved for Bail-Out!

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

Biolux (Biotronik)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content